Medical AI Alliance
Company Index
Pharma & CDMOKOSDAQ 058820348 approvals37 trials

CMG Pharmaceutical Co., Ltd.

Official website

CMG Pharmaceutical, a Cha Bio Group affiliate, develops ODF-based improved drugs using its STARFILM technology.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2001 and listed on KOSDAQ in 2001, CMG Pharmaceutical is a core affiliate of Cha Bio Group whose main business is the R&D, production, and sale of pharmaceuticals and health functional foods. Using its core STARFILM technology for oral disintegrating films (ODF), it develops improved new drugs with differentiated taste and stability, while expanding its portfolio into anticancer, anti-aging, ophthalmic, health functional food, and mom-and-baby product lines. It also operates an animal pharmaceutical business through an affiliate and is pursuing continued development of new and improved drugs, along with clinical entry and out-licensing of innovative new drugs.

Products & technology

  • STARFILM Technology (Oral Disintegrating Film, ODF)Core formulation technology applied to improved new drug development

Regulatory approvals

data.go.kr

347 Korean MFDS drug approvals · 1980–2026 / 1 Korean MFDS device approvals · 2014

  • MFDS drugZaviron night soft cap.2026-07-15
    Drug · OTC · Notification202602046
  • MFDS drugDestop cap.2026-07-07
    Drug · OTC · Notification202601973
  • MFDS drugRotizet OD Tab. 10/20mg2026-06-30
    Drug · Prescription · Approval202601888
  • MFDS drugRotizet OD Tab. 10/5mg2026-06-30
    Drug · Prescription · Approval202601889
  • MFDS drugRotizet OD Tab. 10/10mg2026-06-30
    Drug · Prescription · Approval202601890
  • MFDS drugVonoprazan tab. 10mg2026-06-30
    Drug · Prescription · Approval202601911
  • MFDS drugVonoprazan tab. 20mg2026-06-30
    Drug · Prescription · Approval202601912
  • MFDS drugCMG pancreas tablet 250002026-06-29
    Drug · OTC · Approval202601827
  • MFDS drugLinetry tab.2026-06-22
    Drug · OTC · Notification202601754
  • MFDS drugMigline Tab.2026-06-19
    Drug · Prescription · Approval202601739
  • MFDS drugDoneplus Tablet (Donepezil Hydrochloride,Memantine Hydrochloride)2026-06-10
    Drug · Prescription · Approval202601637
  • MFDS drugActiveneo soft capsule2026-05-14
    Drug · OTC · Notification202601421
Show 68 more
  • MFDS drugEzverine Tab.2026-05-06
    Drug · OTC · Notification202601332
  • MFDS drugOlo-Luce Eye drops 0.7%2025-12-26
    Drug · Prescription · Approval202503391
  • MFDS drugCalsbone tab.2025-11-21
    Drug · OTC · Notification202503041
  • MFDS drugCMPeratam inj. 2.25g(Piperacillin sodium. Tazobactam sodium)2025-10-28
    Drug · Prescription · Approval202502762
  • MFDS drugMaxbb plus tab.2025-10-20
    Drug · OTC · Notification202502703
  • MFDS drugCMPeratam Inj. 4.5g(Piperacillin sodium. Tazobactam sodium)2025-10-14
    Drug · Prescription · Approval202502650
  • MFDS drugPipen Tablet(Pitavastatin,fenofibrate)2025-08-29
    Drug · Prescription · Approval202502273
  • MFDS drugCubit Soft caps.2025-06-18
    Drug · OTC · Notification202501497
  • MFDS drugDabislim Tab.2025-06-16
    Drug · OTC · Notification202501467
  • MFDS drugZescool plus Tab.2025-06-12
    Drug · OTC · Notification202501437
  • MFDS drugTranexan cap.2025-03-26
    Drug · Prescription · Approval202500704
  • MFDS drugDiastop capsule2025-01-08
    Drug · OTC · Notification202500070
  • MFDS drugCaresmin tab.2025-01-07
    Drug · OTC · Notification202500051
  • MFDS drugForsone tab.2025-01-06
    Drug · OTC · Notification202500033
  • MFDS drugTORAPHEN XR TAB 25mg2024-12-12
    Drug · Prescription · Approval202402953
  • MFDS drugLoxopop plasta2024-12-11
    Drug · OTC · Notification202402921
  • MFDS drugTyxen Powder 160mg2024-12-10
    Drug · OTC · Notification202402904
  • MFDS drugTyxen Powder 500mg2024-12-10
    Drug · OTC · Notification202402905
  • MFDS drugCHEOLSWON Tab.2024-12-03
    Drug · OTC · Notification202402856
  • MFDS drugDiqualux Eye Drops. (single use)2024-12-03
    Drug · Prescription · Approval202402860
  • MFDS drugTORAPHENXR TAB 50mg2024-11-29
    Drug · Prescription · Approval202402827
  • MFDS drugSiman solution2024-11-25
    Drug · OTC · Notification202402767
  • MFDS drugWincold Cough Soft Cap.2024-10-11
    Drug · OTC · Notification202402410
  • MFDS drugWin-cold Soft cap.2024-10-08
    Drug · OTC · Notification202402400
  • MFDS drugOnecold all cough sol.2024-09-19
    Drug · OTC · Notification202402262
  • MFDS drugOnecold Syrup2024-09-10
    Drug · OTC · Notification202402198
  • MFDS drugOnecoldcough Syrup2024-09-10
    Drug · OTC · Notification202402199
  • MFDS drugNosefor Nasal spray2024-09-02
    Drug · OTC · Notification202402127
  • MFDS drugOnecoldnose Syrup2024-08-26
    Drug · OTC · Notification202402040
  • MFDS drugGINKGOMIRAN TAB. 240mg2024-08-26
    Drug · OTC · Notification202402041
  • MFDS drugTokTok Eye Eye drops2024-07-29
    Drug · OTC · Notification202401832
  • MFDS drugAlletoc Tab. 120mg2024-07-23
    Drug · OTC · Notification202401781
  • MFDS drugDexicen Soft Capsule2024-07-15
    Drug · OTC · Notification202401742
  • MFDS drugNbreas capsule2024-06-28
    Drug · OTC · Notification202401588
  • MFDS drugMaxbb tab.2024-06-21
    Drug · OTC · Notification202401505
  • MFDS drugA A Force solution2024-06-03
    Drug · OTC · Notification202401381
  • MFDS drugIbucen Soft Cap.2024-05-28
    Drug · OTC · Notification202401305
  • MFDS drugIbucen eve Soft cap.2024-05-02
    Drug · OTC · Notification202401092
  • MFDS drugFreesdam tablet2024-04-30
    Drug · OTC · Notification202401045
  • MFDS drugTyribin Powder2024-04-29
    Drug · OTC · Notification202401033
  • MFDS drugWin-cold Co Soft Cap.2024-04-18
    Drug · OTC · Notification202400884
  • MFDS drugWhitetion tab.2024-04-18
    Drug · OTC · Notification202400885
  • MFDS drugWin-cold Soft cap.Revoked2024-04-16
    Drug · OTC · Notification202400856
  • MFDS drugWincold Cough Soft Cap.Revoked2024-04-16
    Drug · OTC · Notification202400857
  • MFDS drugCMG View Plus soft capsule2024-03-26
    Drug · OTC · Notification202400647
  • MFDS drugCHAMG soft capsule2024-03-26
    Drug · OTC · Notification202400653
  • MFDS drugCMG Ambroxol Tablet2024-03-26
    Drug · OTC · Notification202400659
  • MFDS drugCMG Mag Soft Cap.2024-03-21
    Drug · OTC · Notification202400582
  • MFDS drugCMG Nicergoline Tab. 30mg2024-02-29
    Drug · Prescription · Approval202400438
  • MFDS drugAlletoc Tab. 60mg2024-02-06
    Drug · OTC · Notification202400279
  • MFDS drugCMG Kyungokgo2024-01-30
    Drug · OTC · Notification202400230
  • MFDS drugCMG ssingssing syrup2024-01-22
    Drug · OTC · Notification202400148
  • MFDS drugNarafil ODF 2.5mg2024-01-12
    Drug · Prescription · Approval202400098
  • MFDS drugCMG Galgeuntang Solution2023-11-06
    Drug · OTC · Notification202303067
  • MFDS drugOnecolenneck Soft Extract(Gupunghaedoktang)2023-11-02
    Drug · OTC · Notification202303051
  • MFDS drugCMG Ssangwhatang Solution2023-11-02
    Drug · OTC · Notification202303053
  • MFDS drugCMG Mag Solution2023-09-18
    Drug · OTC · Notification202302769
  • MFDS drugIbupop plaster(Ibuprofen)2023-09-13
    Drug · OTC · Notification202302745
  • MFDS drugCMG Lux plus eye drop 1.0%2023-08-23
    Drug · OTC · Notification202302508
  • MFDS drugC-cox-plus tab.2023-08-10
    Drug · Prescription · Approval202302410
  • MFDS drugTyxen tablet 500mg(Acetaminophen)2023-07-12
    Drug · OTC · Notification202302139
  • MFDS drugSita Plus extended release tablet 100/1000mg(Sitagliptin,Metformin)2023-06-20
    Drug · Prescription · Approval202301868
  • MFDS drugSita plus extended release tablet 50/1000mg(Sitagliptin,Metformin)2023-06-20
    Drug · Prescription · Approval202301869
  • MFDS drugSita plus extended release 50/500mg (Sitagliptin,Metformin)2023-06-20
    Drug · Prescription · Approval202301870
  • MFDS drugSitasingle tablet 100mg2023-06-14
    Drug · Prescription · Approval202301821
  • MFDS drugSitasingle tablet 50mg2023-06-14
    Drug · Prescription · Approval202301822
  • MFDS drugSitasingle tablet 25mg2023-06-14
    Drug · Prescription · Approval202301823
  • MFDS drugSita plus tablet 50/1000mg (Sitagliptin, Metformin)2023-06-12
    Drug · Prescription · Approval202301800

Showing the 80 most recent of 348 records.

Clinical trials

data.go.kr

37 MFDS clinical trial authorisations · 2013–2026 (Bioequivalence 31 · Phase 1 4 · Phase 3 2)

  • BioequivalenceCGC25012026-03-20

    1 trial site

  • BioequivalenceCGN25012026-03-17

    1 trial site

  • Bioequivalence도네듀오정10/20mg(도네페질염산염수화물, 메만틴염산염)2025-04-18

    1 trial site

  • Phase 1CMG1904042024-09-26

    2 trial sites

  • Bioequivalence레미피드서방정150밀리그램(레바미피드)2024-09-02

    1 trial site

  • Bioequivalence카르디날정12.5밀리그램2024-08-08

    1 trial site

  • Bioequivalence레미피드서방정150밀리그램(레바미피드)2024-07-18

    1 trial site

  • Bioequivalence에독신정60밀리그램(에독사반토실산염수화물)2023-11-01

    1 trial site

  • Bioequivalence테잔정50밀리그램(테고프라잔)2023-09-26

    1 trial site

  • Phase 3CMG1903032023-07-26

    24 trial sites

  • Bioequivalence레미피드서방정150밀리그램(레바미피드)2023-07-04

    1 trial site

  • Bioequivalence레미피드서방정150밀리그램(레바미피드)2023-06-01

    1 trial site

Show 25 more
  • Bioequivalence레드로진정(레보드로프로피진)2022-12-28

    2 trial sites

  • Phase 1CMG1904042022-02-28

    2 trial sites

  • Bioequivalence씨콕스캡슐200mg(세레콕시브)2021-12-06

    1 trial site

  • Bioequivalence타리원정10mg(베포타스틴베실산염)2021-11-11

    2 trial sites

  • Bioequivalence나라필구강용해필름2.5밀리그램(나라트립탄염산염)2021-07-02

    2 trial sites

  • Phase 1CMG1903032021-02-24

    2 trial sites

  • Phase 1CMG1903032020-08-14

    2 trial sites

  • Bioequivalence카르디날정25mg(카르베딜롤)2020-01-08

    2 trial sites

  • Phase 3씨엠지올리스타트정120mg(CMG-OLT-120)2019-09-04

    6 trial sites

  • Bioequivalence텔로듀오정80/20밀리그램2019-08-20

    2 trial sites

  • Bioequivalence도네시아정10mg(도네페질염산염)2018-10-29

    2 trial sites

  • Bioequivalence아모르탄정10/160mg2015-12-03

    2 trial sites

  • Bioequivalence씨엠지라베프라졸정20mg(라베프라졸나트륨)2015-12-03

    2 trial sites

  • Bioequivalence에소넬정40mg(에스오메프라졸마그네슘이수화물)2015-11-25

    2 trial sites

  • Bioequivalence씨엠지암로디핀정5mg(암로디핀베실산염)2015-11-25

    1 trial site

  • Bioequivalence로피렐정(클로피도그렐황산염)2015-11-19

    2 trial sites

  • Bioequivalence아로토정(아토르바스타틴칼슘)2015-11-04

    2 trial sites

  • Bioequivalence제대로필구강붕해필름5밀리그램(타다라필)2015-07-22

    2 trial sites

  • Bioequivalence씨콕스정2014-10-30

    2 trial sites

  • Bioequivalence엔테카비르 OTF 구강붕해필름(가칭)2014-10-15

    2 trial sites

  • Bioequivalence타다라필 OTF 구강붕해필름(가칭)2014-08-20

    2 trial sites

  • Bioequivalence아리피프라졸 OTF 10mg2014-07-30

    2 trial sites

  • Bioequivalence쎄레콕시브정2014-06-26

    2 trial sites

  • Bioequivalence아제탄정(염산아젤라스틴)2013-12-20

    2 trial sites

  • Bioequivalence씨엠지로수바스타틴정 10mg(로수바스타틴칼슘)2013-06-11

    2 trial sites

Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

OSANG HEALTHCARE CO.,LTD.1 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

NanoenTek,Inc.1 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

HUMASIS CO., LTD.1 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

Boditech Med Inc.1 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

Precision Biosensor Inc.1 shared

KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.

BioNote, Inc.1 shared

Founded in 2003 and KOSPI-listed in 2022, BioNote develops and manufactures animal diagnostic reagents and bio-content materials.

Sugentech, Inc.1 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

GC Medical Science Corporation1 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Micro Digital Co., Ltd.1 shared

KOSDAQ-listed bioprocess and biomedical company supplying the CELBIC single-use cell culture system and the DxBIC automated analysis system.

Aprogen Biologics Inc.1 shared

Aprogen Biologics develops Remicade, Rituxan, and Herceptin biosimilars and operates a world top-5 scale antibody production facility.

KWANGDONG PHARMACEUTICAL CO.,LTD1 shared

Kwangdong Pharmaceutical, founded in 1963 and KOSPI-listed in 1989, manufactures prescription drugs and beverages.

SD BIOSENSOR INC.1 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition